// App-Quantinova.ai

e12031 : Progesterone receptor, a novel risk factor for paclitaxel-induced peripheral neuropathy.

Researchers

Presenter

  • Zohreh Ghoreishi

Principal Investigators

  • Ali Esfahani

  • Mohammad Asghari Jafarabadi

  • Hormoz Ayromlou

Medical Centers

  • Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, Tabriz, Iran

  • Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, Tabriz, Iran

  • Health Services Management Research Center and Department of Statistics and Epidemiology, Faculty of Health and Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran

  • Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, Tabriz, Iran

Locations

  • Iran

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Peripheral neuropathy

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Progesterone

  • Human epidermal growth factor receptor 2

  • Body mass index

Drug/Treatment

  • estrogen + progesterone

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01049295

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved